Editta Baldini

3.7k total citations
83 papers, 1.5k citations indexed

About

Editta Baldini is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Editta Baldini has authored 83 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Oncology, 40 papers in Pulmonary and Respiratory Medicine and 24 papers in Cancer Research. Recurrent topics in Editta Baldini's work include Lung Cancer Treatments and Mutations (32 papers), Lung Cancer Research Studies (23 papers) and Cancer Treatment and Pharmacology (18 papers). Editta Baldini is often cited by papers focused on Lung Cancer Treatments and Mutations (32 papers), Lung Cancer Research Studies (23 papers) and Cancer Treatment and Pharmacology (18 papers). Editta Baldini collaborates with scholars based in Italy, United States and France. Editta Baldini's co-authors include Pierfranco Conté, Carmelo Tibaldi, Paola Collecchi, G. Gardin, Andrea Ardizzoni, Tiziana Prochilo, B. Salvadori, Paolo Bruzzi, Luca Boni and Gabriella Fontanini and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Editta Baldini

78 papers receiving 1.4k citations

Peers

Editta Baldini

ONCOL

PRM

EPIDE

Mauro Mansutti Italy

J. Ottaway Canada

R. Largillier France

Giuseppe Lo Russo Italy

Katherine Liau United States

G. Ross United Kingdom

Daniel Vorobiof South Africa

Alessandra Ravaioli Italy

Jenny Huang United States

Diana Lake United States

Mauro Mansutti Italy

Editta Baldini

1.1k ×0.9

ONCOL

713 ×1.4

331 ×0.7

PRM

187 ×0.6

90 ×0.5

EPIDE

Citations per year, relative to Editta Baldini Editta Baldini (= 1×) peers Mauro Mansutti

Countries citing papers authored by Editta Baldini

Since Specialization

Citations

This map shows the geographic impact of Editta Baldini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Editta Baldini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Editta Baldini more than expected).

Fields of papers citing papers by Editta Baldini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Editta Baldini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Editta Baldini. The network helps show where Editta Baldini may publish in the future.

Co-authorship network of co-authors of Editta Baldini

This figure shows the co-authorship network connecting the top 25 collaborators of Editta Baldini. A scholar is included among the top collaborators of Editta Baldini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Editta Baldini. Editta Baldini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Camerini, Andrea, Francesca Mazzoni, Vieri Scotti, et al.. (2024). Efficacy and Safety of Chemotherapy after Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer. Journal of Clinical Medicine. 13(13). 3642–3642. 3 indexed citations

Tibaldi, Carmelo, et al.. (2022). Incidence of COVID-19 Infection in Advanced Lung Cancer Patients Treated with Chemotherapy and or Immunotherapy. 5(2). 1 indexed citations

Barlési, Fabrice, Makoto Nishio, Manuel Cobo, et al.. (2018). IMpower132: Efficacy of atezolizumab (atezo) + carboplatin (carbo)/cisplatin (cis) + pemetrexed (pem) as 1L treatment in key subgroups with stage IV non-squamous non-small cell lung cancer (NSCLC). Annals of Oncology. 29. viii743–viii744. 44 indexed citations

Rossi, E., et al.. (2014). Integrative Approach with Diet and Complementary Medicine in Oncology: The Experience in the Hospital of Lucca (Italy). The Journal of Alternative and Complementary Medicine. 20(5). A139–A140. 1 indexed citations

Tiseo, Marcello, Luca Boni, Francesca Ambrosio, et al.. (2014). Italian Multicenter Phase III Randomized Study of Cisplatin–Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive Stage Small Cell Lung Cancer: Treatment Rationale and Protocol Design of the GOIRC-AIFA FARM6PMFJM Trial. Clinical Lung Cancer. 16(1). 67–70. 17 indexed citations

Gori, Stefania, Matteo Clavarezza, Salvatore Siena, et al.. (2012). Adjuvant chemotherapy of pT1a and pT1b breast carcinoma: results from the NEMESI study. BMC Cancer. 12(1). 158–158. 12 indexed citations

Boni, C., Marcello Tiseo, Luca Boni, et al.. (2012). Triplets versus doublets, with or without cisplatin, in the first-line treatment of stage IIIB–IV non-small cell lung cancer (NSCLC) patients: a multicenter randomised factorial trial (FAST). British Journal of Cancer. 106(4). 658–665. 19 indexed citations

Amadori, Dino, Rosella Silvestrini, Mario De Lena, et al.. (2010). Randomized phase III trial of adjuvant epirubicin followed by cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) versus CMF followed by epirubicin in patients with node-negative or 1–3 node-positive rapidly proliferating breast cancer. Breast Cancer Research and Treatment. 125(3). 775–784. 19 indexed citations

Mastro, Lucia Del, Béatrice Dozin, Enrico Aitini, et al.. (2007). Timing of adjuvant chemotherapy and tamoxifen in women with breast cancer: findings from two consecutive trials of Gruppo Oncologico Nord-Ovest–Mammella Intergruppo (GONO-MIG) Group. Annals of Oncology. 19(2). 299–307. 12 indexed citations

10.

Lucchi, Marco, Franca Melfi, Editta Baldini, et al.. (2007). Sentinel Lymph Node Mapping: Detection of Micrometastases by Polymerase Chain Reaction in Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 2(5). S37–S37. 1 indexed citations

11.

Venturini, Marco, Lucia Del Mastro, Enrico Aitini, et al.. (2005). Dose-Dense Adjuvant Chemotherapy in Early Breast Cancer Patients: Results From a Randomized Trial. JNCI Journal of the National Cancer Institute. 97(23). 1724–1733. 107 indexed citations

12.

Baldini, Editta, G. Gardin, Piergiorgio Giannessi, et al.. (2003). Accelerated versus standard cyclophosphamide, epirubicin and5-fluorouracil or cyclophosphamide, methotrexate and5-fluorouracil: a randomized phase III trial in locally advanced breast cancer. Annals of Oncology. 14(2). 227–232. 49 indexed citations

13.

Danesi, Romano, Federico Innocenti, Stefano Fogli, et al.. (2002). Pharmacokinetics and pharmacodynamics of combination chemotherapy with paclitaxel and epirubicin in breast cancer patients. British Journal of Clinical Pharmacology. 53(5). 508–518. 41 indexed citations

14.

Conté, Pierfranco, Alessandra Gennari, Valentina Guarneri, et al.. (2001). Epirubicin/taxane combinations in breast cancer: experience from several Italian trials.. PubMed. 15(5 Suppl 7). 21–3. 3 indexed citations

15.

Collecchi, Paola, et al.. (1999). Cyclin-D1 expression in node-positive (N+) and node-negative (N?) infiltrating human mammary carcinomas. International Journal of Cancer. 84(2). 139–144. 20 indexed citations

16.

Conté, Pierfranco, Editta Baldini, G. Gardin, et al.. (1996). Chemotherapy with or without estrogenic recruitment in metastatic breast cancer. A randomized trial of the Gruppo Oncologico Nord Ovest (GONO). Annals of Oncology. 7(5). 487–490. 9 indexed citations

17.

Baldini, Editta, Carmelo Tibaldi, E. Pfanner, et al.. (1996). Phase II Study of Oral Doxifluridine in Elderly Patients with Advanced Non-Small-Cell Lung Cancer. American Journal of Clinical Oncology. 19(6). 592–594. 9 indexed citations

18.

Baldini, Editta, Carmelo Tibaldi, Antonio Chella, et al.. (1996). Phase II study of vinorelbine/ifosfamide/cisplatin for the treatment of advanced non-small-cell lung cancer. Annals of Oncology. 7(7). 747–749. 17 indexed citations

19.

Baldini, Editta, G. Gardin, P. Pronzato, et al.. (1993). Stimulation of Human Breast Cancer in Vivo. Annals of the New York Academy of Sciences. 698(1). 418–422. 3 indexed citations

20.

Ardizzoni, Andrea, R. Rosso, F Salvati, et al.. (1991). Combination Chemotherapy and Interferon α2b in the Treatment of Advanced Non-Small-Cell Lung Cancer. American Journal of Clinical Oncology. 14(2). 120–123. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact